-
1.发明申请公开(公告)号：US20220362172A1
公开(公告)日：2022-11-17
申请号：US17874984
申请日：2022-07-27
发明人： Todd R. Henderson , David Griffin
摘要： The present application relates to compositions comprising avocado/soybean unsaponifiables (“ASU”) and cannabis, and related methods of use. In one embodiment, the cannabis is a cannabis oil extract that is combined with ASU to reduce inflammatory responses and inflammation in humans and animals.
-
公开(公告)号：US20190290608A1
公开(公告)日：2019-09-26
申请号：US16437701
申请日：2019-06-11
发明人： Todd Henderson , David Griffin , David Bledsoe
IPC分类号： A61K31/198 , A61K38/38 , A61K36/575 , A61K31/4045 , A61K31/197 , A61K36/756 , A61K31/7076 , A61K45/06 , A61K38/01 , A61K9/00
摘要： An anxiolytic composition includes a synergistic combination of one or more of an extract of magnolia, an extract of phellodendron, an L-theanine, a whey protein composition, and/or an s-adenosylmethionine (SAMe).
-
公开(公告)号：US11241444B2
公开(公告)日：2022-02-08
申请号：US16830454
申请日：2020-03-26
发明人： Todd Henderson , David Griffin
IPC分类号： A61K31/56 , A61K31/05 , A61K36/63 , A61K36/324
摘要： Compositions are described including a combination of hydroxytyrosol and 3-O-acetyl-11-keto-β-boswellic acid. The hydroxytyrosol may be sourced from an olive extract and the 3-O-acetyl-11-keto-β-boswellic acid may be sourced from a Boswellia serrata extract. The compositions may be formulated for oral administration to a mammalian or an avian subject. Methods for preventing or reducing an inflammatory response in connective tissue are provided, the methods comprising orally administering the compositions to a subject in need thereof.
-
公开(公告)号：USD941457S1
公开(公告)日：2022-01-18
申请号：US29730685
申请日：2020-04-07
设计人： Brian Adams , David Griffin , Hubert Ratkowski
-
5.发明申请公开(公告)号：US20210137870A1
公开(公告)日：2021-05-13
申请号：US17157139
申请日：2021-01-25
发明人： Todd Henderson , David Griffin , David Bledsoe
IPC分类号： A61K31/198 , A61K36/756 , A61K38/01 , A61K45/06 , A61K31/7076 , A61K9/00 , A61K31/197 , A61K31/4045 , A61K36/575 , A61K38/38
摘要： An anxiolytic composition includes a synergistic combination of one or more of an L-theanine, an s-adenosylmethionine (SAMe), and optionally an extract of Magnolia, an extract of Phellodendron, and a whey protein.
-
公开(公告)号：US20180092928A1
公开(公告)日：2018-04-05
申请号：US15494022
申请日：2017-04-21
发明人： Todd Henderson , David Griffin
IPC分类号： A61K31/56 , A61K31/05 , A61K36/63 , A61K36/324 , A61K9/00
CPC分类号： A61K31/56 , A61K31/05 , A61K36/324 , A61K36/63 , A61K2300/00
摘要： Compositions are described including a synergistic combination of hydroxytyrosol and 3-O-acetyl-11-keto-β-boswellic acid. The hydroxytyrosol may be sourced from an olive extract and the 3-O-acetyl-11-keto-β-boswellic acid may be sourced from a Boswellia serrata extract. The compositions may be formulated for oral administration to a mammalian or an avian subject. Methods for treating, repairing, or reducing damage to connective tissue caused by one or more inflammatory mediators and for reducing levels of one or more inflammatory mediators in connective tissue are provided, the methods comprising orally administering the compositions to a subject in need thereof.
-
公开(公告)号：US11980624B2
公开(公告)日：2024-05-14
申请号：US17559571
申请日：2021-12-22
发明人： Todd Henderson , David Griffin
IPC分类号： A61K31/56 , A61K31/05 , A61K36/324 , A61K36/63
CPC分类号： A61K31/56 , A61K31/05 , A61K36/324 , A61K36/63 , A61K36/63 , A61K2300/00 , A61K36/324 , A61K2300/00
摘要： Compositions are described including a synergistic combination of hydroxytyrosol and 3-O-acetyl-11-keto-β-boswellic acid. The hydroxytyrosol may be sourced from an olive extract and the 3-O-acetyl-11-keto-β-boswellic acid may be sourced from a Boswellia serrata extract. The compositions may be formulated for oral administration to a mammalian or an avian subject. Methods for treating, repairing, or reducing damage to connective tissue caused by one or more inflammatory mediators and for reducing levels of one or more inflammatory mediators in connective tissue are provided, the methods comprising orally administering the compositions to a subject in need thereof.
-
公开(公告)号：US20230157984A1
公开(公告)日：2023-05-25
申请号：US18089896
申请日：2022-12-28
发明人： Todd Henderson , David Griffin , David Bledsoe
IPC分类号： A61K31/198 , A61K36/756 , A61K38/01 , A61K45/06 , A61K31/7076 , A61K9/00 , A61K31/197 , A61K31/4045 , A61K36/575 , A61K38/38
CPC分类号： A61K31/198 , A61K9/0053 , A61K31/197 , A61K31/4045 , A61K31/7076 , A61K36/575 , A61K36/756 , A61K38/018 , A61K38/38 , A61K45/06
摘要： An anxiolytic composition formulated for oral administration to a mammal includes a synergistic combination of L-theanine, at least one of magnolia and an extract of magnolia, and at least one of phellodendron and an extract of phellodendron. The composition may include a combination of an extract of Magnolia officinalis and a extract of Phellodendron amurense. The synergistic combination may provide an anxiolytic change in a release pattern of one or more brain neurotransmitters, such as glutamate and/or γ-aminobutyric acid (GABA).
-
公开(公告)号：US20220110946A1
公开(公告)日：2022-04-14
申请号：US17559571
申请日：2021-12-22
发明人： Todd Henderson , David Griffin
IPC分类号： A61K31/56 , A61K36/324 , A61K36/63 , A61K31/05
摘要： Compositions are described including a synergistic combination of hydroxytyrosol and 3-O-acetyl-11-keto-β-boswellic acid. The hydroxytyrosol may be sourced from an olive extract and the 3-O-acetyl-11-keto-β-boswellic acid may be sourced from a Boswellia serrata extract. The compositions may be formulated for oral administration to a mammalian or an avian subject. Methods for treating, repairing, or reducing damage to connective tissue caused by one or more inflammatory mediators and for reducing levels of one or more inflammatory mediators in connective tissue are provided, the methods comprising orally administering the compositions to a subject in need thereof.
-
公开(公告)号：USD941458S1
公开(公告)日：2022-01-18
申请号：US29746031
申请日：2020-08-11
设计人： Brian Adams , David Griffin , Hubert Ratkowski
-
-
-
-
-
-
-
-
-
搜索结果
33 条记录 (耗时 0.013 秒)
